Chronic Kidney Disease Stocks List

Recent Signals

Date Stock Signal Type
2021-05-06 AKBA Bollinger Band Squeeze Range Contraction
2021-05-06 AKBA 20 DMA Resistance Bearish
2021-05-06 ARDX Calm After Storm Range Contraction
2021-05-06 ARDX Narrow Range Bar Range Contraction
2021-05-06 ARDX Stochastic Buy Signal Bullish
2021-05-06 AZN NR7 Range Contraction
2021-05-06 AZN Cup with Handle Other
2021-05-06 CNCE New 52 Week Low Weakness
2021-05-06 CNCE Hammer Candlestick Bullish
2021-05-06 CNCE Lower Bollinger Band Walk Weakness
2021-05-06 FGEN Doji - Bullish? Reversal
2021-05-06 FGEN Fell Below 20 DMA Bearish
2021-05-06 KDNY New Uptrend Bullish
2021-05-06 KDNY NR7 Range Contraction
2021-05-06 KDNY Non-ADX 1,2,3,4 Bullish Bullish Swing Setup
2021-05-06 LJPC Bollinger Band Squeeze Range Contraction
2021-05-06 LJPC Death Cross Bearish
2021-05-06 OPK Lower Bollinger Band Walk Weakness
2021-05-06 OPK Bollinger Band Squeeze Range Contraction
2021-05-06 OPK Stochastic Reached Oversold Weakness
2021-05-06 PIRS Jack-in-the-Box Bearish Bearish Swing Setup
2021-05-06 PIRS Stochastic Buy Signal Bullish
2021-05-06 PIRS Calm After Storm Range Contraction
2021-05-06 RMTI Bollinger Band Squeeze Range Contraction
2021-05-06 TCDA New 52 Week Closing Low Bearish
2021-05-06 TCDA Lower Bollinger Band Walk Weakness
2021-05-06 TCDA Expansion Breakdown Bearish Swing Setup

Recent News for Chronic Kidney Disease Stocks

Date Stock Title
May 7 FGEN FIBROGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuits Against Fibrogen, Inc. - FGEN
May 7 FGEN Shareholder Alert: Bernstein Litowitz Berger & Grossmann LLP Announces the Filing of a Securities Class Action Lawsuit Against FibroGen, Inc.
May 7 AZN PRESS DIGEST-Financial Times - May 7
May 7 AZN Japan may approve AstraZeneca, Moderna vaccines as early as May 20 -Nikkei
May 6 FGEN The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of FGEN, CS and CCXI
May 6 TCDA CORRECTING and REPLACING -- Tricida Announces First Quarter 2021 Financial Results
May 6 FGEN HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Advises ACAD, FGEN, RMO Investors with Losses to Contact the Firm, Updates on Securities Class Actions and Application Deadlines
May 6 TCDA Tricida EPS misses by $0.03
May 6 AZN India's COVID-19 cases soar with over 412,000 confirmed
May 6 TCDA Tricida Announces First Quarter 2021 Financial Results
May 6 AZN UPDATE 1-On vaccinating the globe, Blinken warns: 'We have to speed this up'
May 6 AZN U.S. backing waiver of patent protection for vaccines is a ‘complex issue’: Doctor
May 6 SNY U.S. backing waiver of patent protection for vaccines is a ‘complex issue’: Doctor
May 6 SNY Regeneron (REGN) Q1 Earnings Beat on Strong Eylea & Dupixent
May 6 AZN AstraZeneca COVID-19 vaccine is now offered to all adults in Germany
May 6 AZN UPDATE 1-Germany to allow AstraZeneca COVID-19 vaccine for all adults
May 6 AZN On vaccinating the globe, Blinken warns: 'We have to speed this up'
May 6 AZN COLUMN-Shifting sands of COVID-19 vaccine supply race give U.S. new advantage
May 6 FGEN LAWSUITS FILED AGAINST VRM, FGEN and PTON - Jakubowitz Law Pursues Shareholders Claims
May 6 FGEN Important Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds FibroGen, Inc. Investors of Securities Fraud Class Action Lawsuit

Chronic kidney disease (CKD) is a type of kidney disease in which there is gradual loss of kidney function over a period of months or years. Early on there are typically no symptoms. Later, leg swelling, feeling tired, vomiting, loss of appetite, or confusion may develop. Complications may include heart disease, high blood pressure, bone disease, or anemia.Causes of chronic kidney disease include diabetes, high blood pressure, glomerulonephritis, and polycystic kidney disease. Risk factors include a family history of the condition. Diagnosis is generally by blood tests to measure the glomerular filtration rate and urine tests to measure albumin. Further tests such as an ultrasound or kidney biopsy may be done to determine the underlying cause. A number of different classification systems exist.Screening at-risk people is recommended. Initial treatments may include medications to manage blood pressure, blood sugar, and lower cholesterol. NSAIDs should be avoided. Other recommended measures include staying active and certain dietary changes. Severe disease may require hemodialysis, peritoneal dialysis, or a kidney transplant. Treatments for anemia and bone disease may also be required.Chronic kidney disease affected 753 million people globally in 2016, including 417 million females and 336 million males. In 2015 it resulted in 1.2 million deaths, up from 409,000 in 1990. The causes that contribute to the greatest number of deaths are high blood pressure at 550,000, followed by diabetes at 418,000, and glomerulonephritis at 238,000.

More about Chronic Kidney Disease
Browse All Tags